Accelerating PK Noncompartmental Analysis to Protect Regulatory Timelines
Learn how Spaulding Clinical, in partnership with Aplos Analytics, cut PK noncompartmental analysis timelines by two weeks for Alume Biosciences to...
blog
Updates Coming to Aplos NCA in March: Building a Faster, More Connected PK Workflow
Aplos NCA March release preview: an all-new web interface with a new dashboard, unlimited analyses, end-to-end PK study workflows, and table/plot...
AI in Pharmacokinetics: From Faster Analyses to Better Decisions
AI is reshaping pharmacokinetics and clinical pharmacology by moving scientists upstream, standardizing workflows, and opening new scientific...
Wrapping Up the Year: Aplos Analytics Holiday Recap
Celebrate the holiday season with Aplos Analytics as we look back on a year of growth, new partnerships, and major enhancements to Aplos NCA
Streamlining Data Cleaning in Aplos NCA
Aplos NCA integrates rule-based data cleaning into pharmacokinetic workflows, helping scientists move from raw data to validated results with...
Aplos Analytics and Metrum Research Group Partner to Transform Pharmacometric Workflows
Aplos Analytics and Metrum Research Group partner to integrate Aplos NCA into Metworx, streamlining pharmacometric workflows in one cloud platform.
How Spaulding Clinical Accelerated PK Analysis with Aplos NCA
Spaulding Clinical turned to Aplos NCA, to streamline the entire NCA workflow, from setup and calculation to export.
Transforming the Future of PK Analysis: An Interview with Nathan Teuscher
Transforming the PK analysis landscape - An interview by Bioanalysis Zone
Reevaluating Non-Compartmental Analysis in Pharmacokinetics: A Data-Centric Perspective
Discover how Aplos NCA simplifies pharmacokinetics with faster, cloud-based PK software. Learn which PK parameters really matter in non-compartmental...
Don’t Wait Until Your License Expires to Make a Change
Instead of making a rushed, high-stakes decision under pressure, the better approach is to explore new tools early. Aplos NCA makes this easy. Our...